{"protocolSection": {"identificationModule": {"nctId": "NCT01573949", "orgStudyIdInfo": {"id": "11-002909"}, "organization": {"fullName": "University of California, Los Angeles", "class": "OTHER"}, "briefTitle": "A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)", "officialTitle": "A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)"}, "statusModule": {"statusVerifiedDate": "2020-08", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-12"}, "primaryCompletionDateStruct": {"date": "2012-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-03-29", "studyFirstSubmitQcDate": "2012-04-09", "studyFirstPostDateStruct": {"date": "2012-04-10", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-08-20", "resultsFirstSubmitQcDate": "2020-08-20", "resultsFirstPostDateStruct": {"date": "2020-09-04", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-08-20", "lastUpdatePostDateStruct": {"date": "2020-09-04", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Tamara Horwich", "investigatorTitle": "Tamara Horwich, MD, MS", "investigatorAffiliation": "University of California, Los Angeles"}, "leadSponsor": {"name": "University of California, Los Angeles", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The Ahmanson-UCLA Cardiomyopathy Center is conducting a clinical research study that will assess the use of the medication metformin to improve quality of life, exercise capacity, and improved outcomes in heart failure patients with pre-DM or early DM (type II).\n\nIf the patient participates in this study, the patient will receive the drug metformin for approximately 3 months. During the study the patient will undergo comprehensive testing which includes blood draws and echocardiograms. The patient will also fill out a questionnaire. The patient must be 18 years old to participate."}, "conditionsModule": {"conditions": ["Diabetes", "Heart Failure"], "keywords": ["Heart Failure", "Diabetes", "Pre-diabetes", "Early type II diabetes", "Metformin", "Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 7, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Metformin", "type": "EXPERIMENTAL", "description": "Metformin will be started at 500 mg PO BID and pending lab values may be titrated to 1000 mg PO BID at 1 month.", "interventionNames": ["Drug: Metformin"]}], "interventions": [{"type": "DRUG", "name": "Metformin", "description": "Metformin will be started at 500 mg PO BID and pending lab values may be titrated to 1000 mg PO BID at 1 month for a duration of 3 months.", "armGroupLabels": ["Metformin"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Health-Related Quality of Life (HRQoL)", "description": "HRQoL as assessed by the Minnesota Living With Heart Failure Questionnaire (MLHFQ)\n\nThe MLHFQ is a self-administered questionnaire for patients with HF, comprising 21 items rated on six-point Likert scales, representing different degrees of impact of HF on HRQoL, from 0 (none) to 5 (very much). It provides a total score range 0-105. Lower scores indicate better health-related quality of life (HRQoL).", "timeFrame": "3 months"}], "secondaryOutcomes": [{"measure": "Glycated Hemoglobin (HbA1c)", "description": "The HbA1c test measures how much glucose is bound to hemoglobin in the red blood cells. The test shows the average level of glucose in blood for the past 3 months (the average lifespan of red blood cells). If glucose levels have been high over recent weeks, the hemoglobin A1c test will be higher.", "timeFrame": "3 months"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "description": "Obtained from Echocardiography", "timeFrame": "3 months"}, {"measure": "Creatinine Level as a Measure of Renal Function", "description": "Serum creatinine", "timeFrame": "3 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* symptomatic HF of any etiology\n* age \u2265 18 years\n* fasting blood sugar equal or greater than 100 mg/dL, or pre-DM (HbA1c 5.7 - 6.4%) or early DM (HbA1c \u2265 6.5%)\n\nExclusion Criteria:\n\n* current metformin therapy or other anti-diabetic therapy\n* previous intolerance to metformin therapy\n* renal dysfunction (Cr \\>1.5 in men or \\> 1.4 in women or creatinine clearance \\< 60 ml/minute)\n* history of lactic acidosis\n* current or planned pregnancy or breast-feeding", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "90 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Tamara Horwich, MD, MS", "affiliation": "University of California, Los Angeles", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Ahmanson-UCLA Cardiomyopathy Center", "city": "Los Angeles", "state": "California", "zip": "90095", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "7"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "7"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "59", "spread": "8"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "7"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "1"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "6"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "7"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "7"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Health-Related Quality of Life (HRQoL)", "description": "HRQoL as assessed by the Minnesota Living With Heart Failure Questionnaire (MLHFQ)\n\nThe MLHFQ is a self-administered questionnaire for patients with HF, comprising 21 items rated on six-point Likert scales, representing different degrees of impact of HF on HRQoL, from 0 (none) to 5 (very much). It provides a total score range 0-105. Lower scores indicate better health-related quality of life (HRQoL).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Full Range", "unitOfMeasure": "score on a scale", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "37", "lowerLimit": "1", "upperLimit": "91"}]}]}, {"title": "Three Months", "categories": [{"measurements": [{"groupId": "OG000", "value": "37", "lowerLimit": "6", "upperLimit": "86"}]}]}]}, {"type": "SECONDARY", "title": "Glycated Hemoglobin (HbA1c)", "description": "The HbA1c test measures how much glucose is bound to hemoglobin in the red blood cells. The test shows the average level of glucose in blood for the past 3 months (the average lifespan of red blood cells). If glucose levels have been high over recent weeks, the hemoglobin A1c test will be higher.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of glycated hemoglobin", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.1", "spread": "0.4"}]}]}, {"title": "Three Months", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.2", "spread": "0.4"}]}]}]}, {"type": "SECONDARY", "title": "Left Ventricular Ejection Fraction (LVEF)", "description": "Obtained from Echocardiography", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percent ejection fraction", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "25", "spread": "8"}]}]}, {"title": "Three Months", "categories": [{"measurements": [{"groupId": "OG000", "value": "26", "spread": "9"}]}]}]}, {"type": "SECONDARY", "title": "Creatinine Level as a Measure of Renal Function", "description": "Serum creatinine", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "0.2"}]}]}, {"title": "Three Months", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "0.2"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "3 months", "eventGroups": [{"id": "EG000", "title": "Metformin", "description": "Metformin at 500 mg PO BID and pending lab values may have been titrated to 1000 mg PO BID at 1 month.", "seriousNumAffected": 0, "seriousNumAtRisk": 7, "otherNumAffected": 0, "otherNumAtRisk": 7}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Tamara Horwich, MD, MS", "organization": "University of California Los Angeles", "email": "thorwich@mednet.ucla.edu", "phone": "310-825-8816"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000011236", "term": "Prediabetic State"}, {"id": "D000018149", "term": "Glucose Intolerance"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000006943", "term": "Hyperglycemia"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "relevance": "LOW"}, {"id": "M14117", "name": "Prediabetic State", "asFound": "Pre-diabetes", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M20295", "name": "Glucose Intolerance", "asFound": "Pre-diabetes", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M9994", "name": "Hyperglycemia", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC14", "name": "Heart and Blood Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}